Top Markets
Coin of the day
Hvsen Biotechnology Co., Ltd. Hvsen Biotechnology Co., Ltd.

Hvsen Biotechnology Co., Ltd.

300871
Rank in Stocks #11646
Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses... Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses on the global research, development, and manufacturing of macrolide active pharmaceutical ingredients (APIs) and finished drug products. The company's diverse product portfolio features tylvalosin, offered in both raw material form and various preparations, along with florfenicol preparations and a broader selection of other macrolide-based offerings. Additionally, Hvsen produces a range of veterinary pharmaceuticals, available as both raw ingredients and finished drugs, alongside traditional Chinese medicine extracts.
Share Price
$3.35
Last synced: 2026-08-28
Market Cap
$675.48M
Change (1 day)
0.26%
Change (1 year)
5.11%
Country
CN
Trade Hvsen Biotechnology Co., Ltd. (300871)

Category

P/B ratio for Hvsen Biotechnology Co., Ltd. (300871)
P/B ratio as of 2026 TTM: 0
According to Hvsen Biotechnology Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Hvsen Biotechnology Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH